<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03059654</url>
  </required_header>
  <id_info>
    <org_study_id>FOMSCU 2200</org_study_id>
    <nct_id>NCT03059654</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Percutaneous Dilatation Tracheostomy: Does it Have a Role in Obese Patients?</brief_title>
  <official_title>Ultrasound-guided Percutaneous Dilatation Tracheostomy: Does it Have a Role in Obese Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Suez Canal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Suez Canal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the usefulness of ultrasound-guided percutaneous dilatation tracheostomy PCT in&#xD;
      obese patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the work: to evaluate the usefulness of ultrasound-guided percutaneous dilatation&#xD;
      tracheostomy PCT in obese patients.&#xD;
&#xD;
      Study objectives:&#xD;
&#xD;
      Primary: determine the duration of the procedure in both groups.&#xD;
&#xD;
      Secondary: determine the incidence of complications in both groups.&#xD;
&#xD;
      Setting of the study: This study will be conducted in the intensive care unit at Suez Canal&#xD;
      University Hospital in Ismailia, Egypt.&#xD;
&#xD;
      Study design: prospective, randomized comparative clinical trial.&#xD;
&#xD;
      Sample size: At 95% level of confidence and 80% power of study, 30 patients per group will be&#xD;
      sufficient to detect a difference of 15.1 ± 19.9 minutes between both groups using the&#xD;
      following equation.&#xD;
&#xD;
      Where n= sample size&#xD;
&#xD;
      Z α/2 = 1.96 (The critical value that divides the central 95% of the Z distribution from the&#xD;
      5% in the tail)&#xD;
&#xD;
      Zβ = 0.84 (The critical value that separates the lower 20% of the Z distribution from the&#xD;
      upper 80%)&#xD;
&#xD;
      σ = the estimate of the pooled standard deviation&#xD;
&#xD;
      µ1 = mean in the study group&#xD;
&#xD;
      µ2 = mean in the control group&#xD;
&#xD;
      (Bradley D., Karen I, et al, 2001)&#xD;
&#xD;
      Material and methods:&#xD;
&#xD;
      After obtaining the informed consent from patients' relatives the enrolled patients will be&#xD;
      randomized into two study groups using table of random numbers:&#xD;
&#xD;
        1. Surgical tracheostomy (group S)&#xD;
&#xD;
        2. Ultrasound guided PCT (group U)&#xD;
&#xD;
      Past medical and surgical history will be taken from relatives of the patients. Examination&#xD;
      of the site of skin incision for signs of infection or surgical or burn scars. Lab&#xD;
      investigation will be done confirming that there is no coagulopathy (PT, INR, PTT and&#xD;
      platelets)&#xD;
&#xD;
      Anesthesia will be achieved during the procedure with Propofol bolus of 1.5 - 2.5 mg / kg&#xD;
      given intravenously. Analgesia will be provided by boluses of 1 µg / kg Fentanyl and&#xD;
      relaxation will be achieved by 0.15 mg/kg Cis-atracurium intravenously if needed.&#xD;
&#xD;
      Patients will be ventilated with synchronized intermittent mandatory ventilation (SIMV) mode&#xD;
      with FiO2 1.0 during the procedure.&#xD;
&#xD;
      The patients will be monitored continuously with heart rate, invasive blood pressure, 5-leads&#xD;
      electrocardiogram, end-tidal capnogram and pulse oximetry (SpaO2).&#xD;
&#xD;
      The skin from the chin to the 3rd intercostals space will be sterilized with Povodine iodine&#xD;
      10% and the area around it will be covered with antiseptic drab.&#xD;
&#xD;
      Technique&#xD;
&#xD;
      In surgical tracheostomy group (group S):&#xD;
&#xD;
      The patient will be positioned in the supine position achieving hyperextension of the neck&#xD;
      with roles behind the patient back.&#xD;
&#xD;
      An Ear-Nose-Throat surgeon will perform the surgical tracheostomy procedure after withdrawing&#xD;
      the oral endotracheal tube to a level above the tracheostomy site.&#xD;
&#xD;
      The duration of the procedure will be estimated from the start of skin incision to the&#xD;
      insertion of the tracheostomy tube into the trachea with confirmation by capnography and&#xD;
      direct visualization of carina by bronchoscope though the tracheostomy tube.&#xD;
&#xD;
      In the ultrasound group (group U):&#xD;
&#xD;
      The patient position will be the same as done for surgical tracheostomy to achieve neck&#xD;
      hyperextension. Two operators will perform the procedure, one will perform the ultrasound&#xD;
      guided PCT and the other will visualize the procedure with fiber optic bronchoscope through&#xD;
      the oral endotracheal.&#xD;
&#xD;
      An ultrasound examination of the anterior neck will be done identifying superficial veins,&#xD;
      thyroid isthmus, cricoids, and tracheal cartilages to determine the site of needle puncture.&#xD;
      After infiltrating the puncture site with Lidocaine 1% with Epinephrine 1:200,000 the&#xD;
      catheter over needle will be advanced (in-plane) till it penetrates the anterior wall of the&#xD;
      trachea using a 10-Heartz linear ultrasound probe (GE Healthcare, LOGIQ e ultrasound BT 12).&#xD;
&#xD;
      Next we will remove the needle leaving the catheter to introduce the J-guide wire after&#xD;
      confirming the position of the needle visually by fiber optic bronchoscope and by aspiration&#xD;
      of air through a saline syringe.&#xD;
&#xD;
      Then we will remove the ultrasound probe and the operator will pass the single beveled curved&#xD;
      dilator (Blue Rhino) dilating the skin to the diameter required then the tracheostomy tube&#xD;
      will be inserted into the trachea. Inflation of the tracheostomy will be done followed by&#xD;
      connection of anesthetic breathing circuit confirming the proper position of the tracheostomy&#xD;
      tube by capnography, chest expansion and lung sliding sign bilaterally.&#xD;
&#xD;
      For both groups the fiber optic bronchoscope will be also withdrawn from the oral&#xD;
      endotracheal tube and reintroduced through the tracheostomy tube for detection of&#xD;
      complications.&#xD;
&#xD;
      A chest X-ray will be obtained 3 hours later for confirmation of tracheostomy tube position&#xD;
      and detection of early pneumothorax.&#xD;
&#xD;
      Data collection&#xD;
&#xD;
      The following data will be collected:&#xD;
&#xD;
      Gender, age (years), height (meters), weight (kilograms), body mass index (BMI) and the&#xD;
      Sequential organ failure assessment (SOFA) will be recorded.&#xD;
&#xD;
      Heart rate, Blood pressure, SpaO2, End-tidal CO2 will be recorded every one minute.&#xD;
      Anatomical landmark data in the form of trachea deviation, enlarged thyroid gland and&#xD;
      apparent vessels at the puncture site will be recorded. Ultrasound data including tracheal&#xD;
      deviation, level of the isthmus of thyroid gland, puncture site, subcutaneous vessels, the&#xD;
      tracheal diameter (centimeters) and skin-to-anterior tracheal thickness (centimeters) will be&#xD;
      recorded.&#xD;
&#xD;
      In (group S) the duration of the procedure will be timed from the start of land mark&#xD;
      identification to the insertion of the tracheostomy tube and in (group U) the duration of the&#xD;
      procedure will be timed from the start of ultrasound examination of the neck to the insertion&#xD;
      of the tracheostomy tube (measured in minutes).&#xD;
&#xD;
      Early complication such as esophageal injury, posterior tracheal wall injury, massive&#xD;
      bleeding, tracheostomy malpositioning, hypoxemia (pulse oximetry &lt; 90%), hypotension&#xD;
      (systolic blood pressure &lt; 90 mmHg, tracheal cuff puncture and tracheal ring fractures will&#xD;
      be recorded. Also late complications such as tracheal subglottic stenosis, stomal infection,&#xD;
      pneumothorax and subcutaneous emphysema will be recorded.&#xD;
&#xD;
      Ethical consideration&#xD;
&#xD;
        -  The ultrasound technology has been used in anesthesia and intensive care successfully&#xD;
           and it is non-invasive facilitating most procedures done in both fields especially in&#xD;
           obese patients.&#xD;
&#xD;
        -  A written informed consent will be obtained from the patients or patients' relatives&#xD;
           before being involved in the study.&#xD;
&#xD;
        -  The steps of the study; the aims, the benefits and disadvantages, all will be discussed&#xD;
           with the patients or patients' relatives.&#xD;
&#xD;
        -  The patient has the right to refuse participation.&#xD;
&#xD;
        -  Any abnormal results will be managed according to traditional methods.&#xD;
&#xD;
        -  Confidentiality of all data and test results of all the study population are preserved.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of the procedure in both groups in minutes</measure>
    <time_frame>average forty five minutes.</time_frame>
    <description>From start of procedure till skin closure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of complications in both groups</measure>
    <time_frame>four weeks</time_frame>
    <description>From start of procedure till hospital discharge or death.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Tracheostomy Techniques</condition>
  <arm_group>
    <arm_group_label>Ultrasound PCT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guide Percutaneous tracheostomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical tracheostomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical tracheostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tracheostomy</intervention_name>
    <arm_group_label>Surgical tracheostomy</arm_group_label>
    <arm_group_label>Ultrasound PCT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Critically ill patients aged over 18 years old needing tracheostomy.&#xD;
&#xD;
          2. Both genders.&#xD;
&#xD;
          3. Obese patients with neck circumference ≥ 40 cm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with coagulopathy (partial thromboplastin time &gt; 50 seconds and international&#xD;
             normalization ratio &gt; 1.5 or platelets count &lt; 80000 / mm3).&#xD;
&#xD;
          2. History of difficult laryngoscopy (Cormack-Lehane Grade 2b view) documented on&#xD;
             intubation.&#xD;
&#xD;
          3. Requirement of high Positive End Expiratory Pressure (PEEP &gt; 10 cmH2O) or high&#xD;
             fraction inspired oxygen (FiO2 &gt; 0.8).&#xD;
&#xD;
          4. Infection at the site of tracheostomy.&#xD;
&#xD;
          5. Previous neck surgery or radiotherapy.&#xD;
&#xD;
          6. Hypersensitivity to local anesthetics.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed E. Abdel-Ghaffar, MD</last_name>
    <phone>+201003179831</phone>
    <email>mohamed_abdelghafa@med.suez.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed A Elsadany, MD</last_name>
    <phone>+201097973797</phone>
    <email>sadany20@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Suez Canal University Hospital</name>
      <address>
        <city>Ismailia</city>
        <zip>41522</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Hefny, MD</last_name>
      <phone>+20643210111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Suez Canal University hospital</name>
      <address>
        <city>Ismailia</city>
        <zip>41522</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Hefny, MD</last_name>
      <phone>+20643210111</phone>
    </contact>
    <investigator>
      <last_name>Mohamed A Elsadany, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed E Abdel-Ghaffar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amr Helmy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmed M El-Lilly, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed E Ibrahem, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>February 20, 2017</last_update_submitted>
  <last_update_submitted_qc>February 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Suez Canal University</investigator_affiliation>
    <investigator_full_name>Mohamed Emad El-Din Abdel-Ghaffar</investigator_full_name>
    <investigator_title>Professor and chairman, department of Anesthesia and Intensive Care, Faculty of Medicine.</investigator_title>
  </responsible_party>
  <keyword>Percutaneous tracheostomy</keyword>
  <keyword>surgical tracheostomy</keyword>
  <keyword>airway ultrasound</keyword>
  <keyword>intensive care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

